4 results on '"Yang, Dong"'
Search Results
2. Decoy peptides targeted to protein phosphatase 1 inhibit dephosphorylation of phospholamban in cardiomyocytes
- Author
-
Oh, Jae Gyun, Kim, Jihwa, Jang, Seung Pil, Nguen, Mai, Yang, Dong Kwon, Jeong, Dongtak, Park, Zee Yong, Park, Sung-Gyoo, Hajjar, Roger J., and Park, Woo Jin
- Subjects
- *
PROTEIN phosphatase inhibitors , *HEART cells , *PEPTIDES , *DEPHOSPHORYLATION , *PHOSPHOLAMBAN , *PHOSPHOPROTEIN phosphatases , *SARCOPLASMIC reticulum , *PHOSPHORYLATION - Abstract
Abstract: Cardiac sarcoplasmic reticulum Ca2+-ATPase (SERCA2a) plays a crucial role in Ca2+ handling in cardiomyocytes. Phospholamban (PLB) is an endogenous inhibitor of SERCA2a and its inhibitory activity is enhanced via dephosphorylation by protein phosphatase 1 (PP1). Therefore, the inhibition of PP1-mediated dephosphorylation of PLB might be an efficient strategy for the restoration of reduced SERCA2a activity in failing hearts. We sought to develop decoy peptides that would mimic phosphorylated PLB and thus competitively inhibit the PP1-mediated dephosphorylation of endogenous PLB. The phosphorylation sites Ser16 and Thr17 are located within the flexible loop region (amino acids 14–22) of PLB. We therefore synthesized a 9-mer peptide derived from this region (ΨPLB-wt) and two pseudo-phosphorylated peptides where Ser16 was replaced with Glu (ΨPLB-SE) or Thr17 was replaced with Glu (ΨPLB-TE). These peptides were coupled to the cell-permeable peptide TAT to facilitate cellular uptake. Treatment of adult rat cardiomyocytes with ΨPLB-SE or ΨPLB-TE, but not with ΨPLB-wt, significantly elevated the phosphorylation levels of PLB at Ser16 and Thr17. This increased phosphorylation of PLB correlated with an increase in contractile parameters in vitro. Furthermore, the perfusion of isolated rat hearts with ΨPLB-SE or ΨPLB-TE, but not with ΨPLB-wt, significantly improved left ventricular developed pressure that had been previously impaired by ischemia. These data indicate that ΨPLB-SE and ΨPLB-TE efficiently prevented dephosphorylation of PLB by serving as decoys for PP1. Therefore, these peptides may provide an effective modality to regulate SERCA2a activity in failing hearts. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
3. Transcription coactivator Eya2 is a critical regulator of physiological hypertrophy
- Author
-
Lee, Seung Hee, Kim, Jooyeon, Ryu, Joo Young, Lee, Suho, Yang, Dong Kwon, Jeong, Dongtak, Kim, Jaetaek, Lee, Sang-Hee, Kim, Jin Man, Hajjar, Roger J., and Park, Woo Jin
- Subjects
- *
PHYSIOLOGY , *HYPERTROPHY , *LUCIFERASES , *CHROMATIN , *PHOSPHORYLATION , *TRANSCRIPTION factors , *GENES - Abstract
Abstract: Despite its significant clinical implications, physiological hypertrophy remains poorly understood. In this study, the transcription coactivator Eya2 was shown to be up-regulated during physiological hypertrophy. Transgene- or adenovirus-mediated overexpression of Eya2 led to up-regulation of mTOR, a critical mediator of physiological hypertrophy. Luciferase reporter and chromatin immunoprecipitation assays revealed that Eya2 directly binds to and activates mTOR expression. The phosphorylation of mTOR downstream molecules was significantly enhanced in Eya2 transgenic (TG) hearts, implying that the Eya2-mediated induction of mTOR expression leads to an elevated mTOR activity. The transcription factor Six1 was also up-regulated during physiological hypertrophy and formed a complex with Eya2. Luciferase reporter and electrophoretic mobility shift assays revealed that the Eya2-Six1 complex binds to and enhances the expression of mTOR in a synergistic manner. Under pressure overload, Eya2 transgenic hearts developed hypertrophy which exhibited important molecular signatures of physiological hypertrophy, as assessed by gene expression profiling and measurements of expression levels of physiological hypertrophy-related genes by quantitative (q) RT-PCR. Examination of heart sections under electron microscopy revealed that the mitochondrial integrity remained largely intact in Eya2 transgenic mice, but not in wild-type littermates, under pressure overload. This finding was confirmed by measurements of mitochondrial DNA contents and the expression levels of mitochondrial function-related genes by qRT-PCR. These data suggest that Eya2 in a physical complex with Six1 plays a critical role in physiological hypertrophy. The cardioprotective effect of Eya2 appears to be due, at least in part, to its preservation of mitochondrial integrity upon pressure overload. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
4. PICOT is a critical regulator of cardiac hypertrophy and cardiomyocyte contractility
- Author
-
Cha, Hyeseon, Kim, Ji Myoung, Oh, Jae Gyun, Jeong, Moon Hee, Park, Chang Sik, Park, Jaeho, Jeong, Hyeon Joo, Park, Byung Keon, Lee, Young-Hoon, Jeong, Dongtak, Yang, Dong Kwon, Bernecker, Oliver Y., Kim, Do Han, Hajjar, Roger J., and Park, Woo Jin
- Subjects
- *
CARDIAC hypertrophy , *REGULATION of heart contraction , *HEART cells , *CONTRACTILITY (Biology) , *THIOREDOXIN , *PHOSPHORYLATION , *LABORATORY mice , *PHYSIOLOGY - Abstract
Abstract: PICOT (PKC-interacting cousin of thioredoxin) was previously shown to inhibit the development of cardiac hypertrophy, concomitant with an increase in cardiomyocyte contractility. To explore the physiological function of PICOT in the hearts, we generated a PICOT-deficient mouse line by using a gene trap approach. PICOT−/− mice were embryonic lethal indicating that PICOT plays an essential role during embryogenesis, whereas PICOT+/− mice were viable with no apparent morphological defects. The PICOT protein levels were reduced by about 50% in the hearts of PICOT+/− mice. Significantly exacerbated cardiac hypertrophy was induced by pressure overload in PICOT+/− mice relative to that seen in wild type littermates. In line with this observation, calcineurin-NFAT signaling was greatly enhanced by pressure overload in the hearts of PICOT+/− mice. Cardiomyocytes from PICOT+/− mice exhibited significantly reduced contractility, which may be due in part to hypophosphorylation of phospholamban and reduced SERCA activity. These data indicate that the precise PICOT protein level significantly affects the process of cardiac hypertrophy and cardiomyocyte contractility. We suggest that PICOT plays as a critical negative regulator of cardiac hypertrophy and a positive inotropic regulator. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.